UPB - Upstream Bio, Inc.
8.81
-1.340 -15.210%
Share volume: 397,898
Last Updated: 04-23-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$10.15
-1.34
-0.13%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | |
| Report Date | 11-07-2024 | 03-12-2025 | |
| Cash flow financing | 0.000 | 270.648 M | |
| Other financing cash flows | 0.000 | 28.000 K | |
| Cash flow | 0.000 | 292.944 M | |
| Net income | -15.992 M | 0.000 | |
| Depreciation | 0.000 | 49.000 K | |
| Changes in inventories | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 41.908 M | |
| Net Borrowings | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | |
| Cash Change | 0.000 | 292.944 M |
